Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Gross Profit (2020 - 2025)

Historic Gross Profit for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $94.2 million.

  • Bioventus' Gross Profit rose 72.47% to $94.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $382.0 million, marking a year-over-year increase of 273.21%. This contributed to the annual value of $388.2 million for FY2024, which is 1829.2% up from last year.
  • Latest data reveals that Bioventus reported Gross Profit of $94.2 million as of Q3 2025, which was up 72.47% from $102.1 million recorded in Q2 2025.
  • Bioventus' Gross Profit's 5-year high stood at $103.6 million during Q2 2024, with a 5-year trough of $59.6 million in Q2 2021.
  • Moreover, its 5-year median value for Gross Profit was $86.3 million (2023), whereas its average is $85.8 million.
  • Per our database at Business Quant, Bioventus' Gross Profit surged by 8913.23% in 2021 and then tumbled by 1547.15% in 2022.
  • Quarter analysis of 5 years shows Bioventus' Gross Profit stood at $87.8 million in 2021, then dropped by 15.47% to $74.2 million in 2022, then rose by 16.33% to $86.3 million in 2023, then increased by 18.95% to $102.7 million in 2024, then fell by 8.21% to $94.2 million in 2025.
  • Its Gross Profit stands at $94.2 million for Q3 2025, versus $102.1 million for Q2 2025 and $83.1 million for Q1 2025.